United Health Products Issues Update on HemoStyp®South Korea MFDS Application

HENDERSON, Nev., Jan. 30, 2018 (GLOBE NEWSWIRE) -- United Health Products, Inc. (UHP) (OTC:UEEC), manufacturer and marketer of HemoStyp, a patented hemostatic gauze for the healthcare and wound care sectors, today announced that Quantum Health Group, one of its international distribution partners, has advised UHP that it has filed an application to have HemoStyp qualify for class III use in general internal surgical procedures with the Ministry of Food and Drug Safety (MFDS) in South Korea. Quantum has further advised UHP that it anticipates a response within 70 days.

About MFDS The Ministry of Food and Drug Safety provides the vision of "Safe Food and Drug, Healthy People, Well-being Society", we are making extensive efforts to safeguard consumers and promote the public health by ensuring the safety of all foods, drugs, cosmetics, herbal medicines, and medical devices that we have in our daily lives. The importance of risk management for food and drug safety is ever growing and the scope of management is expanding. As more and more people are seeking to maintain a healthy lifestyle, it is crucial to ensure that the food and drugs they have are safe and effective. We, at the MFDS, are dedicated to advance our mission of protecting and promoting the health of the people in the same way we care for our own families, and help create a safer and healthier food and drug environment. http://www.mfds.go.kr/eng/index.do?nMenuCode=10

About Quantum Health Group Quantum Health Group, the medical division of Australian Stock Exchange listed Quantum Energy Limited is a leading medical equipment distribution, solutions provider and manufacturer in SE Asia. Quantum Health Group is comprised of direct subsidiary offices in Australia, New Zealand, Thailand, China and Korea. Quantum Health Group specializes in sales, service and clinical support of high technology medical equipment in radiology, oncology, nuclear medicine and women’s healthcare markets; we represent leading global healthcare manufacturers including Samsung, Philips, Accuray and IBA cyclotrons. Quantum Health Group is also a manufacturer of medical supplies and high technology healthcare systems in Korea. Quantum Health Group employs a large team of technical and clinical specialists including medical physicists, radiation therapists, nuclear medicine technologists, radiographers, sonographers and field service engineers to ensure our medical system are professionally installed, maintained and our customers are trained ensuring their equipment provides the highest level of diagnostic performance for improved patient care. www.q-healthgroup.com

About United Health Products, Inc. United Health Products (UHP) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UHP is focused on identifying new markets and applications for its products, and expanding its current markets.

For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com

Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.

Company Contact United Health Products: 877-358-3444
IR contact: Philippe Niemetz, PAN Consultants Ltd., 212 344-6464

Ads

You May Also Like

Intercept Announces New OCA Data to be Presented at The Liver Meeting® 2018

NEW YORK, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical ...

Cellectar Biosciences Announces $7.76 Million Registered Direct Offering Priced At-The-Market

MADISON, Wis., Oct. 10, 2017 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ:CLRB) (“Cellectar” or ...